Munich Reinsurance Co Stock Corp in Munich bought a new position in shares of CVS Health Corporation (NYSE:CVS – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 459,492 shares of the pharmacy operator’s stock, valued at approximately $47,534,000.
Several other hedge funds and other institutional investors also recently bought and sold shares of CVS. BlackRock Inc. bought a new position in shares of CVS Health during the 2nd quarter worth about $12,747,462,000. Norges Bank bought a new stake in shares of CVS Health in the fourth quarter valued at about $1,666,265,000. Bank of America Corp DE grew its position in CVS Health by 148.0% during the second quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock worth $2,398,868,000 after buying an additional 13,836,701 shares in the last quarter. Wellington Management Group LLP increased its stake in CVS Health by 193.2% during the fourth quarter. Wellington Management Group LLP now owns 18,564,392 shares of the pharmacy operator’s stock valued at $1,473,270,000 after acquiring an additional 12,233,675 shares during the period. Finally, Pzena Investment Management LLC bought a new position in CVS Health during the second quarter valued at about $1,217,558,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of brokerages have commented on CVS. Wells Fargo & Company raised their price objective on CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Piper Sandler restated an “overweight” rating on shares of CVS Health in a research report on Wednesday, August 26th. Morgan Stanley raised their target price on CVS Health from $106.00 to $111.00 and gave the stock an “overweight” rating in a research report on Thursday, June 4th. Robert W. Baird set a $107.00 price target on shares of CVS Health in a research note on Thursday, August 6th. Finally, Cantor Fitzgerald boosted their price target on shares of CVS Health from $100.00 to $110.00 and gave the company an “overweight” rating in a report on Tuesday, July 7th. Twenty-two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $106.83.
CVS Health Trading Down 0.4%
Shares of CVS opened at $96.80 on Friday. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. The stock has a market cap of $123.80 billion, a PE ratio of 25.61, a PEG ratio of 0.95 and a beta of 0.59. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The stock has a 50 day simple moving average of $100.79 and a 200-day simple moving average of $90.14.
CVS Health (NYSE:CVS – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The business had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. During the same quarter in the previous year, the firm earned $1.81 EPS. CVS Health’s quarterly revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, sell-side analysts predict that CVS Health Corporation will post 8.02 EPS for the current fiscal year.
CVS Health Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were issued a $0.665 dividend. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 annualized dividend and a dividend yield of 2.7%. CVS Health’s dividend payout ratio is presently 70.37%.
CVS Health Company Profile
CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.
Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.
Read More
- Five stocks we like better than CVS Health
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
